Open AccessResearch progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
Author(s) -
Linlin Zheng,
Changcheng Tao,
Zonggui Tao,
Kai Zhang,
Anke Wu,
Jianxiong Wu,
Weiqi Rong
Publication year - 2021
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v13.i10.1136
Subject(s) - sorafenib , medicine , regorafenib , hepatocellular carcinoma , programmed cell death 1 , immunotherapy , lenvatinib , targeted therapy , oncology , pd l1 , cancer research , programmed cell death , cancer , apoptosis , colorectal cancer , biochemistry , chemistry